XML 35 R27.htm IDEA: XBRL DOCUMENT

Stock warrants	9 Months Ended
Mar. 31, 2022
Stock Warrants
Stock warrants	21. Stock warrants On September 7, 2018, the Company entered into a settlement agreement with several investors to settle all disputes by issuing additional unrestricted shares. In connection with the note each individual investor will also receive warrants equal to the number of the shares the investors own as of the effective date of the settlement agreement. The warrants have a life of five years with an exercise price as of the date of exchange. The fair value of the warrants at the grant date was $56,730. As of March 31, 2022 and June 30, 2021, the fair value of the warrant liability was $289 and $1,042, respectively. On February 4, 2020, the Company entered into a warrant agreement with an accredited investor for up to 10,000,000 shares of common stock of the Company at an exercise price of $0.008 per share, subject to adjustment. The warrants have a life of five years with an exercise price as of the date of exchange. The fair value of the warrants at the grant date was $80,000. As of March 31, 2022 and June 30, 2021, the fair value of the warrant liability was $4,000 and $20,000, respectively. As of March 31, 2022 and June 30, 2021, the total fair value of the warrant liability was $4,289 and $21,042, respectively.

Stock warrants

9 Months Ended

Mar. 31, 2022

21. Stock warrants

On September 7, 2018, the Company entered into a settlement agreement with several investors to settle all disputes by issuing additional unrestricted shares. In connection with the note each individual investor will also receive warrants equal to the number of the shares the investors own as of the effective date of the settlement agreement. The warrants have a life of five years with an exercise price as of the date of exchange. The fair value of the warrants at the grant date was $56,730. As of March 31, 2022 and June 30, 2021, the fair value of the warrant liability was $289 and $1,042, respectively.

On February 4, 2020, the Company entered into a warrant agreement with an accredited investor for up to 10,000,000 shares of common stock of the Company at an exercise price of $0.008 per share, subject to adjustment. The warrants have a life of five years with an exercise price as of the date of exchange. The fair value of the warrants at the grant date was $80,000. As of March 31, 2022 and June 30, 2021, the fair value of the warrant liability was $4,000 and $20,000, respectively.

As of March 31, 2022 and June 30, 2021, the total fair value of the warrant liability was $4,289 and $21,042, respectively.